ArticleInvestigacion y educacion en enfermeria2026
Areas of patent innovation regarding diabetic foot ulcers: technological prospecting.
Article in Investigacion y educacion en enfermeria, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To identify areas of innovation in internationally registered patents focused on diabetic foot ulcers. Methods: This is a quantitative technological prospecting of international patents, from 2020 to 2024, in the World Intellectual Property Organization database, using the descriptor "diabetic foot". Results: 1372 patents were found, with the largest number of registrations originating from China (76.38%), the United States (4.74%), the Patent Cooperation Treaty (3.8%), and India (3.1%). The areas of innovation of the patents were classified into treatment (82.1%), prevention (12.2%), and evaluation (5.7%). Among the patents, 72.8% correspond to medical devices and 27.2% to pharmaceutical compounds. Conclusion: The global trend is towards patents for the treatment of diabetic foot complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.